TECH vs. PFE
Compare and contrast key facts about Bio-Techne Corporation (TECH) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TECH or PFE.
Correlation
The correlation between TECH and PFE is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
TECH vs. PFE - Performance Comparison
Loading data...
Key characteristics
TECH:
47.29%
PFE:
23.84%
TECH:
-4.18%
PFE:
-58.96%
TECH:
0.00%
PFE:
-56.84%
Fundamentals
TECH:
$7.89B
PFE:
$126.67B
TECH:
$0.83
PFE:
$1.38
TECH:
60.17
PFE:
16.14
TECH:
1.33
PFE:
0.57
TECH:
6.53
PFE:
2.03
TECH:
3.91
PFE:
1.40
TECH:
$892.59M
PFE:
$62.46B
TECH:
$581.78M
PFE:
$42.09B
TECH:
$245.55M
PFE:
$16.71B
Returns By Period
TECH
N/A
N/A
N/A
N/A
N/A
N/A
PFE
-13.00%
3.63%
-13.62%
-15.14%
-4.61%
0.44%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TECH vs. PFE — Risk-Adjusted Performance Rank
TECH
PFE
TECH vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Techne Corporation (TECH) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TECH vs. PFE - Dividend Comparison
TECH's dividend yield for the trailing twelve months is around 0.48%, less than PFE's 7.63% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TECH Bio-Techne Corporation | 0.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 7.63% | 6.33% | 5.70% | 3.12% | 2.64% | 3.91% | 3.67% | 3.11% | 3.53% | 3.69% | 3.46% | 3.33% |
Drawdowns
TECH vs. PFE - Drawdown Comparison
The maximum TECH drawdown since its inception was -4.18%, smaller than the maximum PFE drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for TECH and PFE. For additional features, visit the drawdowns tool.
Loading data...
Volatility
TECH vs. PFE - Volatility Comparison
Loading data...
Financials
TECH vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Bio-Techne Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TECH vs. PFE - Profitability Comparison
TECH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bio-Techne Corporation reported a gross profit of 193.89M and revenue of 297.03M. Therefore, the gross margin over that period was 65.3%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
TECH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bio-Techne Corporation reported an operating income of 47.42M and revenue of 297.03M, resulting in an operating margin of 16.0%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
TECH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bio-Techne Corporation reported a net income of 34.89M and revenue of 297.03M, resulting in a net margin of 11.8%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.